2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
复制标题
DOI:
10.1093/eurheartj/ehw211
复制
发表时间:
2016-09-21
影响因子:
39.3
通讯作者:
Windecker, Stephan
中科院分区:
文献类型:
--
作者:
Zamorano, Jose Luis;Lancellotti, Patrizio;Windecker, Stephan
The task of developing CPG documents covers not only integration of the most recent research, but also the creation of educational tools and implementation programmes for the recommendations. To implement these documents, condensed pocket guidelines versions, summary slides and an electronic version for digital applications (smartphones, etc.) are produced as well as other educational tools depending on the topic. These versions are abridged and thus, if needed, one should always refer to the full text version, which is freely available on the ESC website. The National Cardiac Societies of the ESC are encouraged to endorse, translate and implement all CPG documents (guidelines and position papers). Implementation programmes are needed because it has been shown that the outcome of disease may be favourably influenced by the thorough application of clinical recommendations. Surveys and registries are needed to verify that real-life daily practice is in keeping with what is recommended in the guidelines, thus completing the loop between clinical research, writing of guidelines, disseminating them and implementing them into clinical practice. Health professionals are encouraged to take the CPG Guidelines and Position Papers fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies. However, these CPG documents do not override in any way whatsoever the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and the patient’s caregiver where appropriate and/or necessary. It is also the health professional’s responsibility to verify the rules and regulations applicable to drugs and devices at the time of prescription.